Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Cellular Biomedicine (CBMG)

Cellular Biomedicine (CBMG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Cellular Biomedicine 1345 AVENUE OF AMERICAS 15TH FLOOR NEW YORK NY 10105 USA

www.cellbiomedgroup.com P: 347-905-5663 F: 347-679-8203

Description:

Cellular Biomedicine Group Inc. is a biomedicine firm engaged in the development of new treatments for degenerative and cancerous diseases utilizing proprietary cell therapy technologies. The Company offers developmental stem cell, progenitor cell, and immune cell projects. It is developing treatments utilizing proprietary cell technologies for the treatment of a range of cancers; joint disease and central nervous system diseases. Cellular Biomedicine Group Inc. is headquartered in Palo Alto, California.

Key Statistics

Overview:

Market Capitalization, $K 384,691
Shares Outstanding, K 19,478
Annual Sales, $ 340 K
Annual Net Income, $ -49,980 K
Last Quarter Sales, $ 30 K
Last Quarter Net Income, $ -17,040 K
60-Month Beta 1.17
% of Insider Shareholders 8.50%
% of Institutional Shareholders 21.98%
Float, K 17,822
% Float 91.50%

Growth:

1-Year Return 17.07%
3-Year Return 16.52%
5-Year Return 12.54%
5-Year Revenue Growth -39.29%
5-Year Earnings Growth -83.92%
5-Year Dividend Growth 0.00%

Per-Share Information:

Latest Earnings Date 02/26/21
Earnings Per Share ttm -2.82
EPS Growth vs. Prev Qtr -25.71%
EPS Growth vs. Prev Year -7.32%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-100 on 02/01/13

CBMG Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -144.80%
Return-on-Assets % -61.68%
Profit Margin % -14,700.00%
Debt/Equity 0.00
Price/Sales 1,184.26
Price/Cash Flow N/A
Price/Book 22.15
Book Value/Share 0.89
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar